Annual report pursuant to Section 13 and 15(d)

Earnings (Loss) Per Common Share (Details)

v3.7.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Basic and diluted numerator:    
Net loss attributable to iBio, Inc. stockholders $ (14,532) $ (9,764)
Preferred stock dividends (90) 0
Net loss available to iBio, Inc. stockholders $ (14,622) $ (9,764)
Basic and diluted denominator:    
Weighted-average common shares outstanding 89,112 80,973
Per share amount $ 0.16 $ 0.12